Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial.

Gloria S. Huang,Melissa A. Merritt,Alan D. Hutson,Howard D. Strickler,Mark H. Einstein,Jurriaan Brouwer-Visser,Nilsa C. Ramirez,Heather A. Lankes,Mona El Bahrawy,Xiaonan Xue,Herbert Yu,Robert S. Mannel,David M. O'Malley,David G. Mutch,Paul DiSilvestro,Melissa A. Geller,Saketh R. Guntupalli,Michael J. Birrer,David Miller,Marc J. Gunter

Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial.

2019

5509Background: Sex hormone and insulin/insulin-like growth factor (IGF) axis signaling pathways play an important role in endometrial cancer development but their role in endometrial cancer recurr...

Keywords:

Gynecologic oncology
Insulin
Insulin-like growth factor
Endometrial cancer
Sex hormone-binding globulin
Internal medicine
Medicine
Oncology
Signal transduction
Growth factor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations